Agastiya Biotech
PrivateLast Round
Series A
Mar 15, 2026
Company Overview
Agastiya Biotech is a biotechnology company that develops novel small molecule oncology therapeutics for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agastiya Biotech Comparables
Compare Agastiya Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspera Biomedicines | 81% | |
| Avenzoar Pharmaceuticals | 78% | |
| StemSynergy Therapeutics, Inc. | 78% |
Agastiya Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 15, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
Monthly visitors grew 463% MoM, from 71 to 400.
Agastiya Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Agastiya Biotech's valuation, stock price, and market status.
Is Agastiya Biotech a public or private company?
Agastiya Biotech is a private company.
What is the current stock price of Agastiya Biotech?
Agastiya Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Agastiya Biotech worth (valuation)?
Valuation information for Agastiya Biotech is not publicly available.
Can I buy Agastiya Biotech stock?
Agastiya Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Agastiya Biotech's last funding round?
Agastiya Biotech's most recent funding round was Series A on March 15, 2026.
Who are the main investors in Agastiya Biotech?
Investor information for Agastiya Biotech is not publicly disclosed.
Will Agastiya Biotech IPO soon?
No public IPO plans have been announced for Agastiya Biotech.
How can I track Agastiya Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Agastiya Biotech's secondary market activity and sign up for updates.